Assertio Holdings, Inc. (ASRT)
| Market Cap | 95.07M |
| Revenue (ttm) | 107.86M |
| Net Income (ttm) | -30.24M |
| Shares Out | 44.63M |
| EPS (ttm) | -0.78 |
| PE Ratio | n/a |
| Forward PE | 7.15 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 551,468 |
| Open | 2.14 |
| Previous Close | 2.19 |
| Day's Range | 2.10 - 2.25 |
| 52-Week Range | 0.85 - 5.80 |
| Beta | 1.66 |
| Analysts | Buy |
| Price Target | 4.00 (+87.8%) |
| Earnings Date | n/a |
About ASRT
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company's pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of mi...
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ASRT stock is "Buy." The 12-month stock price forecast is 4.00, which is an increase of 87.79% from the latest price.
News
Has Assertio (ASRT) Outpaced Other Medical Stocks This Year?
Here is how Assertio (ASRT) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
Despite Fast-paced Momentum, Assertio (ASRT) Is Still a Bargain Stock
Assertio (ASRT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that mad...
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Assertio Holdings, Inc. for Potential Breaches of F...
NEW YORK, Dec. 27, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cl...
Do Options Traders Know Something About Assertio (ASRT) Stock We Don't?
Investors need to pay close attention to Assertio (ASRT) stock based on the movements in the options market lately.
Assertio Shares Gain After Buying Antares' Rheumatoid Arthritis Treatment For $44M
Antares Pharma Inc (NASDAQ: ATRS) divested Otrexup (methotrexate) injection to treat rheumatoid arthritis to a subsidiary of Assertio Holdings Inc (NASDAQ: ASRT) for $44 million inclusive of Otrexup WIP...
Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares P...
Trailing 12 Month Reported Revenues of Otrexup Were $15.5 Million
Assertio (ASRT) Shows Fast-paced Momentum But Is Still a Bargain Stock
Assertio (ASRT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that mad...
Assertio Holdings, Inc. Announces Preliminary Court Approval of Shareholder Derivative Settlement
LAKE FOREST, Ill., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that on October 28, 2021, the Superior Court of the State of Cal...
Assertio Posts Higher Profitability In Q3 Despite Lower Revenues
Assertio Holdings Inc (NASDAQ: ASRT) posted Q3 sales of $25.9 million, down 23% Y/Y, but surpassed the consensus of $22.04 million. Assertio's restructuring plan resulted in cost savings of $40.0 millio...
Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates
Assertio (ASRT) delivered earnings and revenue surprises of 300.00% and 15.57%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Assertio (ASRT) Q3 Earnings Expected to Decline
Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Assertio Holdings, Inc. to Report Third Quarter 2021 Financial Results After the Close of Markets on Thursday, Novemb...
LAKE FOREST, Ill., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release third quarter 2021 financial results on Thu...
Assertio Holdings, Inc. to Participate in Upcoming Investor Events
LAKE FOREST, Ill., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT) today announced that the Company's Chief Executive Officer, Dan Peisert, and Chi...
New Strong Sell Stocks for September 9th
ASRT, CVGW, NTRB, ITRG, and KNBWY have been added to the Zacks Rank #5 (Strong Sell) List on September 9, 2021
New Strong Sell Stocks for September 7th
ASRT, GLDD, MOGO, XPO, and FSUGY have been added to the Zacks Rank #5 (Strong Sell) List on September 7, 2021
Assertio (ASRT) Reports Q2 Loss, Tops Revenue Estimates
Assertio (ASRT) delivered earnings and revenue surprises of -300.00% and 24.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Assertio Reports Second Quarter 2021 Financial Results
Reported Net Product Sales of $24.8 Million
Assertio (ASRT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Assertio Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
LAKE FOREST, Ill., June 04, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that that it received a notification letter from the Listing Qua...
Implied Volatility Surging for Assertio Holdings (ASRT) Stock Options
Investors need to pay close attention to for Assertio Holdings (ASRT) stock based on the movements in the options market lately.
Assertio Holdings, Inc. Announces 1-for-4 Reverse Stock Split
LAKE FOREST, Ill., May 17, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has filed a Certificate of Amendment to its certificate o...
Assertio Holdings, Inc. Announces Adjournment of Annual Meeting of Shareholders
- Adjournment Solely to Vote on the Reverse Split and Proportional Authorized Shares Reduction Proposal (Proposal 2) and Increase in Authorized Shares Proposal (Proposal 3)
3 Penny Stocks That Investors Need to Watch In 2021
Which penny stocks should you know about in 2021? Take a look at these 3 The post 3 Penny Stocks That Investors Need to Watch In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information |...
Assertio Reports First Quarter 2021 Financial Results
Reported Net Product Sales of $26.4 Million, Compared to Prior Year Pro-Forma Net Products Sales of $28.3 Million
Assertio Holdings, Inc. Partners with Cove, a Leading Migraine Telemedicine Platform, To Launch Direct to Patient Dig...
Collaboration will Increase Access to CAMBIA and SPRIX through Cove's Innovative, and Continuous Online Physician Care Collaboration will Increase Access to CAMBIA and SPRIX through Cove's Innovative, a...